Treatment Patterns and Clinical Outcomes Among Patients With HR+/HER2- mBC Receiving Palbociclib Combination Therapy in the US Community Oncology Setting.

Condition:   Breast Cancer Intervention:   Sponsor:   Pfizer Active, not recruiting

Source: ClinicalTrials.gov - July 8, 2020 Category: Research Source Type: clinical trials